\(-ㅂ-)/♡ try ViralVideoDB.com daily viral videos

Dr. Grothey on FDA Approval of Pembrolizumab in MSI-High CRC

Say and pronounce Dr. Grothey On on SuperTTS.com Make Your Own Text-To-Speech Words Instantly

  Info

Description

Axel Grothey, MD, medical oncologist at Mayo Clinic, discusses the FDA approval of pembrolizumab (Keytruda) for the treatment of patients with microsatellite instability-high colorectal cancer (CRC).

Tags

cancer oncology
  Email Video to Friends   Receive Emails for Similar Videos

Email:

  Repeat and Loop Video   Link to Video   Create Short URL  Publish Text About This Video   Share on Facebook, Twitter, and more
  See Recommended Videos For You
Old Cartoons on DVD. Visit and Bookmark: Cool90s.com!

Related

  Dr. Straus on FDA Approval of Pembrolizumab in Hodgkin Lymphoma   Dr. Wakelee on FDA Approval of Frontline Pembrolizumab in NSCLC   Dr. Garcia on FDA Approval of Pembrolizumab in Bladder Cancer   Dr. Diaz on Pembrolizumab for CRC   Dr. Grothey on Treatment Landscape of mCRC   Upfront Use of Immunotherapy for NCSLC   Immunotherapy for HNSCC   Pembrolizumab in Newly Diagnosed Squamous NSCLC   Dr. Spigel on FDA Approval of Pembrolizumab/Chemo Combo in NSCLC   Dr. Gandhi on Pembrolizumab/Chemo Findings in NSCLC and FDA Approval   Upfront Immunotherapy for PD-L1+ NSCLC   Dr. Diaz on Response Rates with Pembrolizumab for CRC   Dr. Balar on the Approval of Pembrolizumab for Bladder Cancer   Combined Immunotherapy and Chemotherapy for NSCLC   Upfront Immunotherapy + Chemotherapy for NSCLC   Dr. Brammer on FDA Approval of Brentuximab Vedotin in CTCL   Dr. Bendell on FDA Approval of Regorafenib in Liver Cancer   Dr. West on FDA Approval of Brigatinib in ALK+ NSCLC   Dr. Al-Kali on FDA Approval of Enasidenib in AML   Upfront Immunotherapy for NSCLC   Review on 2016 FDA Approvals, Halt on AML Trials, and More   Pembrolizumab in MSI-H CRC Tumors   Breakthrough In Leukemia Treatment   New drug trial heals dogs of arthritis   Clarence-based company could become first to sell very low nicotine cigarette   Extended Cut: Should the Terminally Ill Have the Right to Try, Non FDA Approved Drugs?   Durvalumab FDA Approval for Bladder Cancer   The FDA Approval of Atezolizumab in Bladder Cancer   FDA Approval in Carcinoid Syndrome Diarrhea, Priority Reviews in Bladder Cancer and NSCLC, and More   New cancer treatment offers patients hope   Novartis Metastatic Breast Cancer Treatment   Cancer Advance of the Year, FDA Approval for CINV, Breakthrough Designation in TNBC, And More   Dr. Sears on Ongoing Research of Microbiota in CRC   FDA Approval and Priority Review in Ovarian Cancer, End of Part B Payment Model, and More   FDA Approval in Lung Cancer, Priority Reviews in HCC and NHL, and an ODAC Recommendation   FDA Approval: Frontline Ceritinib for ALK+ NSCLC   21st Century Cures Act Passes and 2016 Highlights from SABCS and WCLC   Dr. McKay on FDA Approval of Nivolumab/Ipilimumab in Frontline RCC   FDA Approval in MZL, Delay in Immunotherapy Combos in NSCLC, and 2017 GI Symposium Highlights   FDA Approval in CLL, Recommendation in NSCLC, Missed Endpoint in GBM Study, and More   Dr. Siefker-Radtke on FDA Approval of Frontline Atezolizumab in Bladder Cancer   FDA Approval and 2 Priority Reviews in Bladder Cancer, and ASCO's Cancer Advance of the Year   Dr. Levy on Impact of Nivolumab, Pembrolizumab Approvals in NSCLC   Dr. Plimack on Combo of Pembrolizumab/Epacodostat in Bladder Cancer   Dr. Modest on Study of Surgical Intervention in CRC   Dr. Butterfield on Pembrolizumab in Multiple Subtypes of Sarcoma   Dr. Kelly on the FDA Approval of Ribociclib in HR+ Breast Cancer   Dr. Steinberg on the FDA Approval of Atezolizumab in Bladder Cancer   Dr. Siefker-Radtke on FDA Approval of Durvalumab in Bladder Cancer   Dr. West on FDA Approval of Frontline Alectinib in ALK+ NSCLC   Dr. Erba on the FDA Approval of CPX-351 in AML   Buffalo first city in U.S. to use new ALS drug   FDA Approval of Durvalumab for Bladder Cancer   Nivolumab Lung Cancer Approval Expanded, Abemaciclib Granted Breakthrough Status, and More   How Does The FDA Approve New Drugs?   Dr. Finn on Studies of Pembrolizumab in Hepatocellular Carcinoma   UK's Dr. Thomas Whayne on PCSK9 inhibitors   Reid: Senate Must Act To End Life-Saving Drug Shortages   Dr. Yuregelun Discusses Germline Testing in CRC   Vivek Ramaswamy On Getting An Alzheimer's Drug Approved | Forbes   Expert: New Women's Sex Drug 'A Step Forward'   Dr. Blackwell on Neratinib in HER2+ Breast Cancer   FDA Approves Frontline Nivolumab for Advanced Melanoma   Local man with ALS disappointed with FDA   'Our Cancer Drug Is For Rich Westerners, Not Poor Indians'   Vivek Ramaswamy On Getting An Alzheimer's Drug Approved | Forbes   FDA Approval of Atezolizumab for NSCLC   Treatment for primary progressive Multiple Sclerosis   FDA Approval of Brigatinib for ALK+ NSCLC   FDA Approval Sought in ALL, Early 2017 GU Symposium Highlights, and New HHS Secretary Confirmed   FDA Approval in ALL, Priority Reviews in CML and Breast Cancer, and More   Is This ‘Little Pink Pill’ The Viagra For Women? | NBC Nightly News   Dr. Reidy-Lagunes on FDA Approval of Telotristat Epitrate for Carcinoid Syndrome   A Roadmap for Medical Devices: From Innovative Ideas to the U.S. Market   FDA Approval in Bladder Cancer, Breakthrough Therapy Designation in DLBCL, and More

Popular Today